Equity (Tables)

3 Months Ended

Dec. 31, 2020

Equity [Abstract]

Schedule of Stock-based Compensation Expense - By Award Type

The effect of recording stock-based compensation expense was as follows:

	For the three months
Stock-based Compensation Expense - by award type	ended December 31,
(in thousands)	2020		2019
Employee stock options	$	1	$	5
Restricted stock units and awards		431		376
Performance stock units and awards		317		292
Employee stock purchase plan		89		47
Outside director equity awards and fees in common stock		65		81
Total stock-based compensation expense	$	903	$	801

Schedule of Stock-based Compensation Expense - By Expense Type

	For the three months
Stock-based Compensation Expense - by expense type	ended December 31,
(in thousands)	2020		2019
Cost of revenue	$	141	$	136
Selling, general, and administrative		559		485
Research and development		203		180
Total stock-based compensation expense	$	903	$	801

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net income (loss) per share:

	For the three months
Basic and Diluted Net Income (Loss) Per Share	ended December 31,
(in thousands, except per share)	2020		2019
Numerator:
Income (Loss) from continuing operations	$	2,569	$	(1,335)
Undistributed earnings allocated to common shareholders for basic and diluted net income (loss) per share		2,569		(1,335)
Denominator:
Denominator for basic net income (loss) per share - weighted average shares outstanding		29,503		28,832
Denominator for fully diluted net (income) loss per share - weighted average shares outstanding		30,377		28,832
Net income (loss) per basic share	$	0.09	$	(0.05)
Net income (loss) per fully diluted share	$	0.08	$	(0.05)
Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation		874		1,168

Schedule of Common Stock Reserved for Future Issuances

As of December 31, 2020, we had common stock reserved for the following future issuances:

	Number of Common
	Stock Shares Available for
Future Issuances	Future Issuances
Exercise of outstanding stock options	38,407
Unvested restricted stock units and awards	1,734,697
Unvested performance stock units and awards (at 200% maximum payout)	1,472,000
Purchases under the employee stock purchase plan	312,474
Issuance of stock-based awards under the Equity Plans	637,303
Purchases under the officer and director share purchase plan	88,741
Total reserved	4,283,622